Skip to main content

Advertisement

Table 4 Average direct costs incurred per low- and high-risk NSI

From: Economic benefits of safety-engineered sharp devices in Belgium - a budget impact model

NSI risk category Low High
Source patient Known   Unknown  
Infection status Uninfected Infected Uninfected Infected
Testing €141.20 €141.20 €85.09 €85.09
Staff and administration €68.81 €68.81 €68.81 €68.81
PEP €374.61 €918.76 €918.76
Disease treatment €142.99 €142.99
Total direct cost per NSI €210.01 €727.61 €1,072.66 €1,215.65
Relative incidence within risk category 100% 33% 58% 10%
Total direct cost per NSI, by risk category €210.01 €950.34